Page 8 - Global External News Today

Three poster presentations showing the beneficial effects of lanifibranor on markers of cardiometabolic health in patients with non-cirrhotic NASH fibrosis independent of weight gain observed.the reduction

Inventiva has been selected for inclusion in Euronext's new segment alongside more than 100 high-growth and Tech-driven European companiesInternational investors will be able to track the Euronext Tech

Investegate announcements from INVENTIVA, Inventiva joins the Euronext Tech Leaders segment

Daix (France), Long Island City (New York, United States), June 3, 2022 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small

Investegate announcements from INVENTIVA,  Inventiva announces the presentation of a scientific abstract at the 82nd Scientific Sessions of the American Diabetes Association

Investegate announcements from INVENTIVA, Inventiva announces participation at several investors conferences in May and June 2022

Daix (France), Long Island City (New York, United States), May 23, 2022 - Inventiva (Euronext Paris and Nasdaq: IVA) (the "Company"), a clinical-stage biopharmaceutical company focused on the development

This credit facility is intended to support the progress and expansion of Inventiva's pipelineThe credit facility consists of two tranches of €25 million eachCredit agreement is part of the European Investment

Investegate announcements from INVENTIVA, Inventiva reports 2022 First Quarter Financial Information and provides clinical development update

Press release content from Business Wire. The AP news staff was not involved in its creation.